MarketCap
Facebook
X
Telegram
Orthofix Medical Income Statement 2025-2008 | OFIX
Brief overview of profit and loss at Orthofix Medical
The figures are compared over a five-year interval. According to figures from Orthofix Medical, revenue changed from $407 million to $822 million over five years. Overall revenue changed by +102.3%, equal to an annualized rate of about 15.1%. Top-line growth remained consistently strong over the period.
Gross profit was 305 million dollars at the start and 566 million dollars at the end of the period (+85.8%). The relationship between sales and direct costs deteriorated. Gross margin moved from 74.9% to 68.8%. The business retained less gross profit from each unit of revenue.
Over the period, EBITDA shifted from $24.3 million to −$4.1 million, a change of −116.9%. Operating performance weakened relative to revenue. EBITDA margin moved from 6% to −0.5%. A lower EBITDA share weakens the quality of the result.
Across the five years, the net result shifted from 2.5 million dollars to −92.2 million dollars. The emergence of a loss requires close attention to costs and the operating model.
The market value of the business moved from 828 million dollars to 491 million dollars, or −40.7%. Financial performance is stronger than the share-price trend.
Summary assessment
The indicators point to a weaker financial profile. The constructive conclusion rests on a larger revenue base. The overall view is constrained by declining net profitability, limited operating profitability and a weaker market valuation. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
491 M | 669 M | 476 M | 397 M | 612 M | 828 M | 841 M | 979 M | 1.04 B | 639 M | 742 M | 563 M | 388 M | 721 M | 726 M | 546 M | 449 M | - |
Shares |
39.6 M | 38.1 M | 36.7 M | 20.1 M | 19.7 M | 19.3 M | 18.9 M | 18.5 M | 18.1 M | 18.1 M | 18.8 M | 18.5 M | 18.7 M | 19 M | 18.2 M | 17.6 M | 17.1 M | - |
Historical Prices |
12.4 | 17.6 | 13 | 19.8 | 31.1 | 43 | 46.2 | 52.5 | 54.7 | 36.2 | 39.2 | 30.1 | 22.8 | 39.3 | 35.2 | 31 | 26.2 | 31 |
Net Income |
-92.2 M | -126 M | -151 M | -19.8 M | -38.4 M | 2.52 M | -28.5 M | 13.8 M | 6.22 M | 3.06 M | -2.81 M | -8.54 M | -25.5 M | 51.3 M | -1.07 M | 44.3 M | 24.5 M | - |
Revenue |
822 M | 799 M | 747 M | 461 M | 464 M | 407 M | 460 M | 453 M | 434 M | 410 M | 396 M | 402 M | 401 M | 462 M | 579 M | 3.08 M | - | - |
Cost of Revenue |
256 M | 254 M | 260 M | 124 M | 115 M | 102 M | 101 M | 96.6 M | 93 M | 87.9 M | 86.5 M | 98.9 M | 107 M | 101 M | 96.4 M | 97.1 M | 138 M | - |
Gross Profit |
566 M | 546 M | 486 M | 337 M | 350 M | 305 M | 359 M | 356 M | 341 M | 322 M | 310 M | 303 M | 298 M | 376 M | 440 M | 365 M | 407 M | - |
Operating Income |
-81.4 M | -84.6 M | -139 M | -13.3 M | -8.32 M | -6.27 M | -18.8 M | 30.1 M | 40.8 M | 21.1 M | 9.26 M | 17.1 M | -11.2 M | 74.9 M | 6.61 M | 66 M | 63.9 M | - |
Interest Expense |
8.11 M | -9.62 M | -938 K | -3.15 M | -3.34 M | 8.38 M | -8.14 M | -6.38 M | -4 M | -2.81 M | -259 K | 1.78 M | 1.92 M | 4.58 M | 9.79 M | 11.3 M | 24.8 M | - |
EBITDA |
-4.11 M | -24.6 M | -86 M | 15.8 M | 21.3 M | 24.3 M | 40.1 M | 51.8 M | 58.5 M | 58.3 M | 39.3 M | 35 M | 29.7 M | 93.1 M | 94.6 M | 88.1 M | 86.2 M | - |
Operating Expenses |
- | - | - | - | - | - | 344 M | 323 M | 302 M | 284 M | 292 M | 271 M | 271 M | 285 M | 351 M | 299 M | 343 M | - |
General and Administrative Expenses |
554 M | 533 M | 145 M | 80 M | 69.4 M | 67.9 M | 85.6 M | 84.5 M | 74.4 M | 74.4 M | 87.2 M | 76.8 M | 65.1 M | 53.8 M | 86.5 M | 73 M | 88.9 M | - |
All numbers in USD currency
Quarterly Income Statement Orthofix Medical
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
40.9 M | 40.4 M | 39.8 M | 39.8 M | 39.5 M | 39.2 M | 38.5 M | 38.5 M | 38 M | 37.7 M | 37.2 M | 37.2 M | 36.8 K | 35.7 K | 20.2 M | 20.1 K | 20 K | 19.9 K | 19.8 M | 19.8 K | 19.7 M | 19.5 M | 19.4 M | 19.3 M | 19.2 M | 19.1 M | 19.4 M | 19 M | 18.8 M | 18.8 M | 18.6 M | 18.6 M | 18.4 M | 18.4 M | 18.3 M | 18.2 M | 18.1 M | 18 M | 17.8 M | 18.1 M | 18.1 M | 18.5 M | 18.7 M | 18.9 M | 18.8 M | 18.7 M | 18.6 M | 18.6 M | 18.4 M | 18.2 M | 18.1 M | 18.1 M | 19.1 M | 19.4 M | 19.3 M | 19.1 M | 18.8 M | 18.7 M | 18.5 M | 18.4 M | 18.1 M | 17.9 M |
Net Income |
-15.8 M | -20.9 M | - | -22.8 M | -14.1 M | -53.1 M | - | -27.4 M | -33.4 M | -36 M | - | -28.9 M | -39.4 M | -60.9 M | - | -10.7 M | 2.49 M | -4.46 M | - | -2.17 M | 2.42 M | -5.82 M | - | 4.65 M | -18.4 M | 25.7 M | 11.7 M | -40.5 M | -547 K | 897 K | 8.87 M | -1.21 M | 925 K | 5.23 M | 1.57 M | 3.46 M | 3.85 M | -2.65 M | -3.24 M | 9.9 M | -7.44 M | 3.84 M | 3.37 M | -1.37 M | 3.57 M | -8.38 M | -5.8 M | 452 K | -683 K | -2.51 M | -10.4 M | -18.8 M | -3.01 M | 3.45 M | 23 M | 3.75 M | 8.8 M | 7.35 M | 7.89 M | 10.1 M | 5.4 M | -41.5 M |
Revenue |
211 M | 197 M | - | 206 M | 203 M | 194 M | - | 197 M | 199 M | 189 M | - | 184 M | 187 M | 175 M | - | 114 M | 118 M | 106 M | - | 112 M | 121 M | 106 M | - | 111 M | 73.1 M | 105 M | 121 M | 113 M | 116 M | 109 M | 121 M | 112 M | 112 M | 109 M | 117 M | 105 M | 109 M | 103 M | 109 M | 98.5 M | 104 M | 98.7 M | 105 M | 101 M | 101 M | 89.8 M | 100 M | 101 M | 101 M | 100 M | 106 M | 91.8 M | 97.6 M | 103 M | 116 M | 108 M | 113 M | 116 M | 119 M | 117 M | 117 M | 139 M |
Cost of Revenue |
61.2 M | 57.2 M | - | 57.1 M | 63.6 M | 72 M | - | 61.6 M | 63.9 M | 61.4 M | - | 64.2 M | 67.5 M | 64.9 M | - | 30.6 M | 31.6 M | 28.3 M | - | 28.3 M | 27.4 M | 25.9 M | - | 26.2 M | 23.2 M | 23.4 M | 26.2 M | 24.9 M | 25.8 M | 23.7 M | 25.6 M | 24 M | 22.8 M | 24.1 M | 23.6 M | 23.7 M | 23.2 M | 22.6 M | 23.3 M | 19.9 M | 22.5 M | 22.1 M | 21.4 M | 23.9 M | 21.9 M | 19.3 M | 21.5 M | 25.3 M | 25.4 M | 26.8 M | 34.1 M | 25.1 M | 21.9 M | 25.8 M | 26.8 M | 24.9 M | 24.9 M | 24.1 M | 27.3 M | 23.1 M | 22.8 M | 22.3 M |
Gross Profit |
150 M | 140 M | - | 149 M | 140 M | 122 M | - | 135 M | 135 M | 127 M | - | 120 M | 120 M | 110 M | - | 83.4 M | 86.5 M | 78.1 M | - | 84.1 M | 94 M | 79.7 M | - | 84.7 M | 50 M | 81.4 M | 95.3 M | 88.6 M | 90 M | 85.4 M | 95.5 M | 87.7 M | 88.7 M | 84.6 M | 93.3 M | 81.5 M | 85.8 M | 80.2 M | 85.2 M | 78.6 M | 81.6 M | 76.5 M | 83.2 M | 77.3 M | 79 M | 70.4 M | 78.8 M | 75.7 M | 75.6 M | 73.2 M | 71.8 M | 66.7 M | 75.8 M | 76.4 M | 88.9 M | 80.9 M | 86.7 M | 83 M | 91.3 M | 88.4 M | 85.5 M | 81.3 M |
Operating Income |
-8.13 M | -14.4 M | - | -17 M | -16 M | -48.9 M | - | -18.9 M | -24.9 M | -29.3 M | - | -24.4 M | -36.6 M | -59.7 M | - | -5.79 M | 6.64 M | -3.08 M | - | -313 K | 4.27 M | -2.92 M | - | 4.18 M | -21 M | 6.85 M | 4.1 M | -18.9 M | 451 K | -4.45 M | 12.4 M | 3.91 M | 5.92 M | 7.87 M | 17.9 M | 9.03 M | 8 M | 5.92 M | 7.42 M | 9.27 M | -2.7 M | 7.08 M | 7.38 M | 4.14 M | 4.93 M | -7.19 M | 3.95 M | 6.51 M | 6.7 M | -29 K | -10.1 M | -14.1 M | 6.92 M | 6.07 M | 26.5 M | 16.9 M | 16.6 M | 14.8 M | 8.17 M | 21 M | 12.4 M | -35.6 M |
Interest Expense |
-778 K | -734 K | - | -535 K | 5.73 M | 1.25 M | - | -2.53 M | -2.51 M | -1.27 M | - | -2.36 M | -20 K | 676 K | - | -3.31 M | -3.19 M | -936 K | - | -1.79 M | 951 K | -2.69 M | - | 1.82 M | 5.07 M | -798 K | - | -8.15 M | -236 K | -404 K | - | -5.05 M | -3.64 M | 2.91 M | - | 479 K | 585 K | -4.35 M | - | -634 K | 147 K | 1.83 M | - | -1.74 M | 853 K | 272 K | - | 395 K | 492 K | 468 K | - | 539 K | 455 K | 560 K | - | 464 K | 1.26 M | 2.22 M | - | 2.27 M | 2.2 M | 2.42 M |
EBITDA |
5.14 M | -943 K | - | -4.1 M | 868 K | -14.4 M | - | -3.73 M | -10.9 M | -14.5 M | - | -11.4 M | -23.3 M | -47 M | - | 1.78 M | 13.2 M | 4.44 M | - | 6.84 M | 11.8 M | 4.53 M | - | 13.2 M | -14.1 M | 13.2 M | 4.1 M | -12.6 M | 6.63 M | 1.28 M | 12.4 M | 8.64 M | 10.5 M | 12.2 M | 17.9 M | 24.5 M | 18.4 M | 11 M | 7.42 M | 24.8 M | 7.31 M | 11.9 M | 7.38 M | 4.14 M | 4.93 M | -6.79 M | 3.95 M | 7.02 M | 7.36 M | 5.72 M | -10.1 M | 1.48 M | 17.2 M | 11.1 M | 26.5 M | 32.6 M | 27.7 M | 20.5 M | 8.17 M | 38.2 M | 23.7 M | -30.3 M |
Operating Expenses |
- | - | - | - | - | - | - | 10.9 M | 11.2 M | - | - | 9.55 M | 11.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.2 M | 107 M | 89.6 M | 89.9 M | 83 M | 83.8 M | 82.8 M | 76.7 M | 75.5 M | 72.5 M | 77.8 M | 74.2 M | 77.8 M | 69.3 M | 84.3 M | 69.5 M | 75.8 M | 73.1 M | 74.1 M | 77.6 M | 74.9 M | 69.2 M | 68.9 M | 73.3 M | 81.8 M | 80.8 M | 68.8 M | 69.7 M | 62.3 M | 64.7 M | 71.6 M | 71.7 M | 83.2 M | 69.9 M | 74.1 M | 132 M |
General and Administrative Expenses |
138 M | 135 M | - | 148 M | 136 M | 133 M | - | 130 M | 134 M | 132 M | - | 27.1 M | 34.2 M | 48.8 M | - | 19.3 M | 15.8 M | 19.3 M | - | 16.3 M | 18.3 M | 16.4 M | - | 16.5 M | 15 M | 17.9 M | - | 21.1 M | 21.9 M | 20.5 M | - | 22.3 M | 22 M | 19.4 M | - | 18.1 M | 20.4 M | 18.3 M | - | 19.3 M | 18.5 M | 17 M | - | 19.3 M | 22.5 M | 21.6 M | - | 19.3 M | 18.2 M | 17.3 M | - | 12.9 M | 15.2 M | 18.2 M | - | 13.8 M | 14.3 M | 14.6 M | - | 14 M | 17.3 M | 23 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Orthofix Medical (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
China
Israel
Britain
Canada
